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I N T R O D U C T I O N
P2X  receptors  are  cell  surface  cation  channels  acti-
vated by extracellular ATP (Khakh and North, 2006; 
Burnstock, 2007; Surprenant and North, 2009). In addi-
tion to being present on the plasma membrane, some 
P2X  receptors  are  also  present  within  intracellular   
vesicular  compartments  (Ennion  and  Evans,  2001;   
Bobanovic et al., 2002; Toulmé et al., 2006; Fountain   
et al., 2007; Qureshi et al., 2007; Stokes and Surprenant, 
2009). Seven P2X subunits comprise the P2X receptor 
family (P2X1–P2X7), with strong evidence to suggest 
that one type (P2X4) plays important roles in neuro-
pathic  pain  (Tsuda  et  al.,  2003;  Coull  et  al.,  2005).   
In these studies, the relevant sites of P2X4 expression 
appear  to  be  resident  immune  cells  called  microglia 
(Tsuda  et  al.,  2003).  Thus,  strategies  that  reduce  or 
abolish  P2X4  expression  alleviate  symptoms  such  as   
allodynia that are a hallmark of neuropathic pain mod-
els (Tsuda et al., 2003; Ulmann et al., 2008). In brief, 
these experiments suggest that one important determi-
nant  of  neuropathic  pain  is  up-regulation  of  P2X4   
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receptors in activated microglia located in the dorsal 
horn of the spinal cord (Inoue, 2008). However, several 
issues warrant further study. First, what are the proper-
ties of P2X receptors in microglia, and how do they   
relate to recombinant receptors? Second, how are P2X4 
receptors  up-regulated  in  microglia?  Third,  are  P2X   
receptors also up-regulated in activated microglia from 
other parts of the nervous system? Here, we focused on 
these questions by investigating immortalized cerebel-
lar C8-B4 microglial cells (Alliot et al., 1996) that we   
report only display P2X4 receptor responses when they 
enter the activated state.
P2X4 receptors were identified as the fourth members 
of the P2X family when a single gene product was shown 
to give rise to ion channels with distinct properties (Bo   
et al., 1995; Buell et al., 1996; Séguéla et al., 1996; Soto   
et al., 1996; Wang et al., 1996). Thus, P2X4-mediated re-
sponses desensitized over seconds, displayed inwardly rec-
tifying current–voltage relations that reversed at 0 mV   
in physiological solutions (Fountain and North, 2006),   
and  showed  time-dependent  enhanced  permeability   
to  organic  cations  and  dyes  in  a  species-dependent   
manner  (Khakh  et  al.,  1999a;  Virginio  et  al.,  1999;   
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We investigated the properties and regulation of P2X receptors in immortalized C8-B4 cells of cerebellar microg-
lial origin. Resting C8-B4 cells expressed virtually no functional P2X receptors, but largely increased functional   
expression of P2X4 receptors within 2–6 h of entering the activated state. Using real-time polymerase chain reac-
tion, we found that P2X4 transcripts were increased during the activated state by 2.4-fold, but this increase was not 
reflected by a parallel increase in total P2X4 proteins. In resting C8-B4 cells, P2X4 subunits were mainly localized 
within intracellular compartments, including lysosomes. We found that cell surface P2X4 receptor levels increased 
by 3.5-fold during the activated state. This change was accompanied by a decrease in the lysosomal pool of P2X4 
proteins. We next exploited our findings with C8-B4 cells to investigate the mechanism by which antidepressants 
reduce P2X4 responses. We found little evidence to suggest that several antidepressants were antagonists of P2X4 
receptors in C8-B4 cells. However, we found that moderate concentrations of the same antidepressants reduced 
P2X4 responses in activated microglia by affecting lysosomal function, which indirectly reduced cell surface P2X4 
levels. In summary, our data suggest that activated C8-B4 cells express P2X4 receptors when the membrane inser-
tion of these proteins by lysosomal secretion exceeds their removal, and that antidepressants indirectly reduce 
P2X4 responses by interfering with lysosomal trafficking.
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were made using 4-MΩ borosilicate glass electrodes (World   
Precision Instruments) with an Axopatch 200B or 700A amplifier 
controlled  by  computers  running  pCLAMP10.1  software  via  a 
Digidata 1322A interface (MDS Analytical Technologies). Data 
were filtered at 2 kHz and digitized at >5 kHz. The chamber   
housing the glass coverslips with adherent cells was perfused with 
extracellular buffer at 2–3 ml/min. Drugs were applied to single 
cells using fast applications with a local fast perfusion device   
(SF-77B Perfusion Fast Step; Warner Instruments), resulting in 
complete solution change in <10 ms (Chaumont and Khakh, 
2008; Richler et al., 2008).
Intracellular calcium ion imaging
C8-B4 microglial cells were loaded with 2.5 µM Fluo4-AM (Invit-
rogen) in the presence of pluronic acid (0.05%) in the extracel-
lular buffer for 10 min, and then transferred to a dye-free buffer 
for 30 min before experimentation to allow cleavage of the AM 
ester group. Drugs (ATP or UTP) were applied in the bath for the 
durations indicated in the graphs. For the “0” extracellular Ca
2+ 
experiments,  before  the  experimentation,  the  cells  were  incu-
bated for 2 min in a bath solution containing no added calcium. 
In the experiments where we estimated the concentration of cal-
cium ions in C8-B4 cells, we used FURA2; all calcium imaging   
was performed using instrumentation described by us (Bowser 
and Khakh, 2007).
Western blot analysis of total P2X protein expression  
in relation to  actin in C8-B4 cells
Resting or activated C8-B4 microglial cells were suspended in cell 
lysis buffer containing 20 mM HEPES, 100 mM NaCl, 1 mM DTT, 
1% Triton X-100, and a protease inhibitor cocktail tablet (GE 
Healthcare). Cells were triturated with a 26-gauge syringe needle 
and incubated in the lysis buffer for 30 min at 4°C. This mixture 
was then centrifuged at 13,000 rpm for 30 min at 4°C, and the sol-
uble proteins in the supernatant were transferred into a clean 
tube. Equal amounts of proteins were loaded on 10% SDS-PAGE 
gels  and  transferred  to  nitrocellulose  membrane  (GE  Health-
care). After transfer, membranes were blocked by incubation with 
PBS containing 0.05% Tween and 5% dry milk for 2 h and incu-
bated overnight with antibodies against P2X proteins in PBS con-
taining  5%  milk  at  4°C.  The  antibodies  used  were  anti-P2X3 
(1:500; Neuromics), anti-P2X4 (1:500; Alomone Labs), anti-P2X6 
(1:500; Alomone Labs), and anti-P2X7 (1:500; Alomone Labs). 
After washing three times for 10 min each in PBS/Tween, the 
membranes were incubated with anti–rabbit horseradish peroxi-
dase secondary antibodies (1:10,000; Invitrogen) in PBS contain-
ing  5%  milk  for  1  h  at  room  temperature.  Membranes  were 
washed three times for 10 min each in PBS/Tween, and the pro-
tein bands were imaged using ECL reagent (Thermo Fisher Sci-
entific). Standard  actin controls (anti– actin; 1:1,000; Abcam) 
were included to ensure equal loading and to use for normaliza-
tion of the P2X band intensities. Western blot analysis of P2X re-
ceptors expressed in HEK-293 cells was performed identically, 
except  that  total  proteins  were  harvested  from  HEK-293  cells 
transfected with P2X3, P2X6, and P2X7 plasmids (0.5 µg) in   
35-mm dishes using the Effectene Transfection reagent (QIAGEN).
Surface biotinylation of P2X4 receptors
Live  C8-B4  cell  cultures  were  preincubated  in  their  complete   
media in the absence (lipopolysaccharide [LPS]) or in the pres-
ence of 1 µg/ml LPS and 1 µg/ml LPS plus 1 µM amitriptyline for 
4 h at 37°C. C8-B4 cells were then biotinylated using a Pierce Cell 
Surface Protein Isolation kit (Thermo Fisher Scientific). In each 
experiment,  four  T75-cm
2  flasks  of  80%  confluent  cells  were 
quickly rinsed with ice-cold PBS. Then, C8-B4 cells were incu-
bated for 30 min at 4°C under gentle rocking with membrane- 
impermeant EZ-link sulfo-NHS-SS-biotin dissolved at 0.5 mg/ml 
Toulmé et al., 2006; Casas-Pruneda et al., 2009; Shinozaki 
et al., 2009). Pharmacological experiments also revealed 
some distinctive features of P2X4 receptors: ivermectin 
(IVM) was an allosteric modulator of P2X4 receptors 
(Khakh et al., 1999b; Priel and Silberberg, 2004), they 
were relatively resistant to P2X antagonists (Buell et al., 
1996; Jones et al., 2000), and antidepressants reduced 
P2X4 responses (Nagata et al., 2009). Additionally, P2X4 
receptors form functional heteromers with P2X6 sub-
units (Lê et al., 1998a; Ormond et al., 2006) and un-
dergo interactions with P2X7 receptors (Guo et al., 
2007; Nicke, 2008; Alqallaf et al., 2009; Boumechache   
et  al.,  2009;  Casas-Pruneda  et  al.,  2009;  Murrell- 
Lagnado, 2009). Progress has also been made in under-
standing  the  cell  biology  of  P2X4  receptors,  with 
evidence to suggest that they undergo endocytosis and 
traffic  to  lysosomes  (Bobanovic  et  al.,  2002;  Royle   
et al., 2002; Toulmé et al., 2006; Qureshi et al., 2007; 
Stokes and Surprenant, 2009). Early studies showed that 
P2X4  receptors  were  widely  expressed  in  the  brain   
(Lê et al., 1998b; Rubio and Soto, 2001), whereas more 
recent studies show that they are also expressed in   
microglia and alveolar macrophages (Bowler et al., 
2003; Tsuda et al., 2003; Raouf et al., 2007; Ulmann   
et al., 2008; Stokes and Surprenant, 2009).
The aforementioned studies provide the framework 
and tools to study the properties of P2X receptors in 
C8-B4 cells, to determine if they are homomeric P2X4 
receptors, to characterize their biophysical and phar-
macological properties, and to directly test several plau-
sible  mechanisms  that  may  lead  to  receptor  up- 
regulation in activated immortalized C8-B4 cells (e.g., 
transcript  regulation,  elevated  protein  levels,  and/or 
protein trafficking).
M AT E R I A L S   A N D   M E T H O D S
Materials
All of the reagents were from VWR International, Sigma-Aldrich, 
Tocris Bioscience, Thermo Fisher Scientific, or Ascent Scientific. 
The names of several molecules have been abbreviated.
C8-B4 cell culture
The  mouse  cerebellar  immortalized  microglial  C8-B4  cell  line   
(Alliot et al., 1996) was provided by D. Trisler (University of Maryland 
School of Medicine, Baltimore, MD). The cells were cultured in   
25-cm
2 culture flasks in Dulbecco’s modified Eagle’s medium   
(American Type Culture Collection [ATCC]) supplemented with 
10% fetal bovine serum (ATCC). They were maintained in a humidi-
fied atmosphere of 95% air/5% CO2 at 37°C in a cell culture incuba-
tor. The cells were split one in three when confluence reached 60%, 
which was generally every 5–6 d. To prepare cells for electrophysiol-
ogy, they were plated onto poly-d-lysine–coated glass coverslips.
Whole cell voltage clamp recording
The  extracellular  recording  solution  comprised  (in  mM):  130 
NaCl, 3 KCl, 1 MgCl2, 2 CaCl2, 10 HEPES, and 10 glucose. The   
pipette solution comprised (in mM): 130 KCl, 2 MgCl2, 0.5 CaCl2, 
5 EGTA, and 10 HEPES. Whole cell voltage clamp recordings   Toulme et al. 335
agarose gel electrophoresis. The controls were processed identi-
cally but lacked RT; these gave no detectable bands on the gels. 
The primers (listed as 5 to 3, with the numbers in brackets indi-
cating the length of the amplicon in base pairs) used for RT-PCR 
were: Lyn tyrosine kinase: sense, ACCACGAGCGAGAAATATGG; 
antisense, GAAAGCTCCTGCACTGTTTC (475 bp); and TLR4: 
sense,  GCTTTCACCTCTGCCTTCAC;  antisense,  AGGCGATA-
CAATTCCACCTG (259 bp).
Quantitative real-time PCRs (qPCRs)
RNA  was  extracted  from  C8-B4  cells  as  described  previously 
(Schmid et al., 2002). RNA concentration was assessed by measur-
ing the absorbance at 260 nm and was adjusted to 1 µg/µl. RNA 
integrity and absence of genomic DNA were verified by fractionat-
ing samples by electrophoresis in denaturing gels. Gels were 
stained with ethidium bromide, and the ratio of 28S to 18S RNA 
was quantified. 2 µg of RNA were reverse transcribed using a first-
strand  cDNA  synthesis  kit  according  to  the  manufacturer’s   
instructions (GE Healthcare). Oligonucleotide primers used for 
qPCR  are  listed  in  Table  S1.  All  primer  pairs  were  chosen  to   
anneal with a DNA template at a temperature of 60°C and to   
encompass a coding fragment of 100–300 bp. Real-time qPCR was 
performed as detailed previously (Schmid et al., 2009). In brief, a 
constant amount cDNA (200 ng) from each RT, or each dilution 
of the appropriate standard, was amplified in 25 µl TaqMan PCR 
Core Reagent (Applied Biosystems) according to the manufactur-
er’s instructions. The reaction mixture consisted of 0.5 U Ampli-
Taq Gold polymerase, each of the four dNTPs (0.2 mM), with 
dUTP replacing dTTP, each pair of primers (300 nM), and MgCl2 
(3 mM final concentration). Amplifications were performed in a 
CFX96 real-time PCR machine (Bio-Rad Laboratories). The reac-
tion was started with a step of 10 min at 50°C for the removal of 
uracyl residues incorporated into the cDNAs with 1 U uracyl-N-
glycosylase (AmpErase reagent). This was followed by an incuba-
tion of 10 min at 95°C for AmpliTaq Gold activation, and then 40 
cycles each consisting of 15 s at 95°C and 1 min at 60°C. At the 
end of each experiment, amplification products were fraction-
ated by gel electrophoresis to verify that they migrated as a single 
band with the expected size. Each experimental sample was ana-
lyzed in duplicate. For the quantitative analysis, direct detection 
of PCR products was performed by measuring the progressive   
increase in fluorescence emitted by the binding of SYBR Green to 
double-stranded DNA. Copy number for each molecule (all P2X 
subunits and Lyn tyrosine kinase) was determined based on com-
parisons to standard curves, and for each sample, the copy num-
ber for each molecule was normalized to the expression of the 
endogenous  housekeeping  gene  hypoxanthine  phosphoribosyl 
transferase (HPRT).
Patch clamp photometry to measure fractional calcium  
current (Pf%)
We used a fluorimetric flux technique that we have described in 
detail (Egan and Khakh, 2004; Samways and Egan, 2007). In brief, 
the Pf% was determined by simultaneously measuring total mem-
brane  current  and  fluorescence  in  cells  loaded  with  a  high   
concentration (2 mM) of the calcium-sensitive dye, K5FURA-2 
(Invitrogen). Membrane currents were recorded from single cells 
held at 60 mV. The intracellular solution was as described above 
for  voltage  clamp  recording  but  lacked  EGTA  and  contained   
2 mM K5FURA-2. Light emitted by FURA-2 (380-nm excitation, 
510-nm emission) was gathered by a microscope objective and di-
rected to the input of a Model 714 photomultiplier detection   
system (Photon Technology International). To account for the day-
  to-day variation in the sensitivity of the microscope and photo-
multiplier tube, the FURA-2 signal was normalized to a “bead unit” 
(BU). One BU equaled the average fluorescence of seven Fluo-
resbrite carboxy BB 4.6-µm microspheres (Polysciences, Inc.)   
in ice-cold PBS. At the end of the incubation time, the reaction 
was quenched with a glycine solution and biotinylated cells were 
harvested by a gentle scraping. Cells were then triturated with a 
26-gauge  syringe  needle  and  incubated  in  the  lysis  buffer  for   
30 min at 4°C. This mixture was then centrifuged at 13,000 rpm 
for 10 min at 4°C. A sample of the total proteins was kept to be 
analyzed on an SDS-PAGE gel. The remaining soluble proteins in 
the supernatant were transferred into a clean tube containing the 
Neutravidin agarose resin (Thermo Fisher Scientific) and incu-
bated for 2 h on a rocking platform at room temperature. Beads 
were then washed five times with wash buffer supplemented with 
protease inhibitors (Protease Inhibitor Cocktail; EMD). Finally, 
biotinylated proteins were eluted by incubating the resin with an 
SDS-PAGE Sample buffer (62.5 mM Tris HCl, pH 6.8, 10% glyc-
erol, and 1% SDS) containing a final concentration of 50 mM 
DTT for 2 h on a rocking platform at room temperature. A trace 
amount of bromophenol blue was added to the eluate before its 
analysis  by  Western  blot.  Each  protein  sample  was  quantified   
using the Bio-Rad protein assay (Bio-Rad Laboratories) to load 
equal amounts of proteins on analytical gels. Thus, 10 µg of each 
protein fraction (i.e., surface biotinylated proteins) from three 
replicates for each condition was run on a 10% SDS-PAGE gel.   
After transfer on a nitrocellulose membrane (GE Healthcare), 
membranes  were  blocked  by  incubation  with  PBS  containing 
0.05% Tween and 5% dry milk for 16 h and incubated for 2 h with 
an anti-P2X4 or anti-P2X7 antibody (1:500; Alomone Labs) in 
PBS containing 5% milk at 4°C. After washing three times for   
10 min each in PBS/Tween, the membranes were incubated with 
anti–rabbit horseradish peroxidase secondary antibodies (1:10,000; 
Invitrogen) in PBS containing 5% milk for 1 h at room temperature. 
Membranes were washed three times for 10 min each in PBS/
Tween, and the protein bands were imaged using ECL reagent 
(Thermo Fisher Scientific). Standard  actin controls (anti–  
actin; 1:1,000; Abcam) were included to ensure that there was no 
biotinylation of intracellular proteins.
Immunocytochemistry
C8-B4 cells were fixed for 15 min at room temperature in PBS 
containing 4% sucrose and 3% paraformaldehyde before being 
permeabilized for 10 min at 4°C with 0.1% Triton X-100. Before 
antibody labeling, the cells were incubated for 30 min at room 
temperature in a blocking solution containing 4% FCS and 3% 
BSA. Each primary antibody was then added for 2 h: rabbit   
anti-P2X4 (1:250; Alomone Labs) and mouse anti–lysosomal- 
associated membrane protein 1 (LAMP1; 1:250; Abcam). Sub-
sequently,  the  cells  were  rinsed  three  times  in  PBS  before   
being incubated for 1 h with a secondary antibody coupled to a 
fluorophore:  anti–rabbit  Alexa  488  (1:1,000)  or  anti–mouse   
Alexa 555 (1:1,000). The images were acquired on an Olympus 
Fluoview 300 confocal microscope with a 40× lens and an NA of 0.8.
Qualitative reverse transcription (RT)-PCR analysis of TLR4  
and Lyn tyrosine kinase transcript expression
C8-B4 cells were cultured in 25-cm
2 flasks, and total RNA was pre-
pared with RNA Easy mini total RNA preparation kit (QIAGEN) 
according to the manufacturer’s instructions. RT was performed 
with 0.5 µg of total RNA using random hexamers and Superscript 
II (Invitrogen) in a 20-µl reaction mix. A non-quantitative PCR 
amplification for Lyn tyrosine kinase and TLR4 was performed 
on cDNA samples (4 µl) in a reaction volume of 50 µl containing 
1× PCR buffer, 2 mM MgCl2, 200 µM dNTPs, 200 nM each of for-
ward and reverse primers, and 1 U AmpliTaq Gold DNA poly-
merase (Applied Biosystems). Primer sets were designed based on 
the available rat and mouse sequences and published data. PCR 
amplification included denaturation at 96°C for 5 min, 48 cycles 
at 94°C for 45 s, 58°C for 45 s, and 72°C for 90 s, followed by 72°C 
for 10 min. Samples (10 µl) of PCR product were analyzed by   336 P2X receptors in C8-B4 cells
methods  have  been  described  in  detail  previously  (Eickhorst   
et al., 2002; Khakh and Egan, 2005).
The percent inhibition of the ATP-evoked current by antide-
pressants, or the percent potentiation by IVM, in microglia was 
calculated as follows (Fig. 11). We first measured responses to 
ATP (100 µM for 20s) without applying any antidepressant or 
IVM (the control trace). After a 5-min wait (to allow for recovery 
from desensitization), we applied ATP again, but 5 s into the   
recording switched to a solution containing ATP and either an 
antidepressant or IVM (the test trace). We calculated the percent 
block or potentiation by antidepressant and IVM by offline digital 
subtraction of the normalized control and test traces, and thus   
arithmetically accounted for desensitization during the ATP   
application period (Fig. 11).
Colocalization was assessed using dual-color confocal immuno-
cytochemistry images of P2X4 and LAMP1 using the Quantitative 
Colocalization plug-in for NIH ImageJ. We unambiguously ana-
lyzed colocalization across many cells (n numbers provided in the 
text) by measuring the Pearson’s correlation coefficient (r) and 
comparing these values statistically (e.g., Fig. 9). In analyzing and 
interpreting the data, we followed published guidelines on co-
localization analysis (Zinchuk and Zinchuk, 2008). In brief, we   
interpreted Pearson’s coefficient (which can range from 1 to 1) 
in the following way: 1, perfect negative correlation; 0, no cor-
relation; 1, perfect positive correlation, i.e., colocalization. Pear-
son’s correlation coefficients of greater than 0.5 are interpreted 
as  indicative  of  reliable  colocalization  between  two  spectrally   
separated fluorophores (Zinchuk and Zinchuk, 2008).
In some experiments, we estimated the concentration of rest-
ing and ATP-evoked Ca
2+ signals in C8-B4 cells using ratiometric 
FURA imaging. For this specific set of experiments, calibration   
of the Ca
2+ signal was achieved by permeabilizing the cells with   
10 µM 4-Br A23187, determining the 340/380 ratio minimum 
(Rmin) and maximum (Rmax), and calibrating using algorithms   
(Grynkiewicz et al., 1985) assuming a Kd of 224 nM, where [Ca
2+]i = 
Kd. (R  Rmin)/(Rmax  R) and R is the 340/380 ratio. Data are 
presented as the mean ± SEM from n experiments as indicated in 
the text. Statistical tests were run in Origin or GraphPad Instat 
(GraphPad Software, Inc.), and significance was declared at a   
P value of <0.05.
measured one at a time on the morning of that day’s experi-
ments  (Egan  and  Khakh,  2004;  Samways  and  Egan,  2007).   
The extracellular bath solution was as listed above for voltage 
clamp recording.
Data analysis
Electrophysiological analysis was performed with Clampfit 10.1 
(MDS  Analytical  Technologies),  Igor  Pro  (WaveMetrics,  Inc.), 
and Origin 6.1 or 7.5 (OriginLab Corporation). Image analysis 
was performed with ImageJ (National Institutes of Health [NIH]). 
The figures were assembled in CorelDraw12 (Corel Corporation). 
The Pf% was calculated as
  Pf
Q
Q
Ca
T
% * , = 100  
where QT (the integral of the ligand-gated ionic current) and QCa 
are given by
  I (t)dt = Q ATP T ∫  
  Q
F
F
Ca
Max
=
∆ 380  
FMax is the calibration constant used to relate QCa to F380.   
It was calculated in a separate series of experiments under con-
ditions where QT is expected to equal QCa using described pro-
cedures (Egan and Khakh, 2004; Samways and Egan, 2007). 
Fmax measured in this way was 0.02653726 ± 0.0043728 BU/pC 
(n = 7). Pf% was often measured multiple times in a single cell; 
these measures were then averaged to give the Pf% for the   
individual  cell.  The  relative  ion  permeability  of  NMDG
+  to   
sodium was calculated from reversal potentials using the func-
tion pNMDG
+/pNa
+ = exp(Erev F/RT), where pNMDG
+ is the   
permeability to NMDG
+, pNa
+ is the permeability to Na
+, and 
Erev is the shift in reversal potential between a solution con-
taining Na
+ and the NMDG
+ as the sole extracellular cations.   
F,  R,  and  T  have  their  usual  meaning  (Hille,  2001).  These 
Figure  1.  Basic properties of resting and acti-
vated C8-B4 cells. (A) Representative images of 
C8-B4 cells in culture in the resting state as well 
as in the activated state at various time points 
after the addition of 1 µg/ml LPS. (B) The top 
graph shows the percentage of cells with 0 or 3 
processes, whereas the bottom graph shows the 
average number of processes per cell as a func-
tion of time after the addition of 1 µg/ml LPS. 
The  number  of  cells  with  three  processes  was 
significantly decreased by LPS. Thus, the images 
and graph clearly show that the activated state 
of C8-B4 cells is associated with the loss of pro-
cesses. (C) The agarose gel image qualitatively 
shows RT-PCR results for two markers (TLR4 and 
Lyn tyrosine kinase), whose expression increased 
upon C8-B4 cell activation with the addition of 
LPS. All of the lanes were run on the same gel, 
but an unrelated intervening lane has been re-
moved. This is shown as a break in the gel next to 
the molecular weight markers. This gel image is 
representative of three similar experiments.  Toulme et al. 337
Online supplemental material
Table S1 lists the primer sequences used for qPCR and lengths   
of expected PCR products. Fig. S1 shows a representative gel, 
with molecular weight markers indicating that total P2X4 pro-
tein  levels  are  the  same  for  resting  and  activated  C8-B4  cells. 
Table  S1  and  Fig.  S1  are  available  at  http://www.jgp.org/cgi/ 
content/full/jgp.200910336/DC1.
R E S U LT S
Initial observations
We studied P2X responses in resting and activated C8-B4 
cells (Alliot et al., 1996) by using LPS to trigger cell activa-
tion (Milligan and Watkins, 2009). Although it is possi-
ble that C8-B4 cells in culture exist in a “partially activated 
state,” the activation of microglia in culture is usually 
achieved by an overnight incubation with 0.1–0.5 µg/ml 
LPS or over a briefer time period (Fig. 1) with LPS at   
1 µg/ml (Köles et al., 2008). We chose the latter condi-
tion to ensure that C8-B4 cell activation, imaging, bio-
chemistry,  and  patch  clamp  recordings  could  be 
performed on the same day. In the remainder of this 
paper, we use the term “resting C8-B4 cells” to mean 
those that had not been treated with LPS, and the term 
“activated  C8-B4  cells”  to  mean  those  that  had  been 
treated with LPS. Resting C8-B4 cells had a branched 
morphology,  with  each  cell  typically  displaying  three 
main processes (Fig. 1 A). However, within 6 h of activa-
tion with 1 µg/ml LPS, the C8-B4 cells displayed fewer 
processes, as the cells with three processes decreased in 
proportion (Fig. 1 B). Also diagnostic of the activated 
state, qualitative RT-PCR experiments showed increased 
mRNAs for TLR4 and Lyn tyrosine kinase after C8-B4 
cell activation for >4 h (Fig. 1 C) (Tsuda et al., 2003; 
Tanga et al., 2004; Coull et al., 2005).
ATP-evoked inward currents are up-regulated in activated 
C8-B4 cells
We measured negligible ATP-evoked inward currents in 
resting C8-B4 cells at 60 mV (0.09 ± 0.05 pA/pF, not 
significantly different from 0 pA/pF; n = 16; Fig. 2 A). 
 In contrast, we measured significant and equivalent   
responses within 3 h of activation by 1 µg/ml LPS or 
10 µg/ml fibronectin (n = 5 and 9; Fig. 2, A and B). For 
this  comparison,  we  used  fibronectin  because  it  is 
thought to be a physiological mediator of microglial   
activation (Nasu-Tada et al., 2006; Milligan and Watkins, 
2009). The ATP-evoked inward currents recorded from 
activated C8-B4 cells displayed 10–90% rise times of 100 ± 
16 ms, peak amplitudes of 3.6 ± 0.4 pA/pF, and 28 ± 3% 
Figure  2.  Up-regulation  of  an  ATP-gated  inward  current   
(at 60 mV) in activated C8-B4 cells. (A) The bar graph shows 
peak ATP-evoked currents (IATP) measured in response to 100-µM   
ATP applications for 2 s (at 60 mV) at different time points af-
ter initiation of the activated state by 1 µg/ml LPS. On the right 
are representative traces for the ATP-evoked responses at the in-
dicated time points after the addition of LPS. The ATP-evoked 
inward currents increased with time after LPS, reaching a peak 
at 4–6 h. Subsequently, especially after 24–48 h after LPS, the 
ATP-evoked currents were far smaller and the cells were hard to 
maintain in the whole cell configuration. The remainder of the 
experiments in this paper use 3–6 h of activation by LPS. (B) Ac-
tivation of C8-B4 cells by 10 µg/ml fibronectin and 1 µg/ml LPS 
results in similar increases in peak ATP-evoked currents. On the 
left are representative traces, and the bar graph shows summary 
data (n = 16, 5, and 9 for each bar of the graph). (C) 100-µM ATP- 
and 100-µM UTP-evoked increases in Fluo-4 fluorescence in rest-
ing (LPS) and activated (+LPS) C8-B4 cells. The UTP effect was 
not increased in activated C8-B4 cells, whereas the effect of ATP 
was  significantly  increased.  The  ATP-evoked  change  in  Fluo-4   
fluorescence was largely reduced when the cells were bathed in 
nominally  Ca
2+-free  buffer  for  the  duration  of  the  recordings 
shown (70 s; n = 6–15 for each graph). (D) The traces are rep-
resentative  of  one  cell  (from  seven  similar  experiments)  and 
show that ATP-evoked currents were largely increased in activated   
C8-B4 cells, whereas currents evoked by GABA, ACh, or glutamate 
could not be detected.
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increased in activated microglia (Tsuda et al., 2008). All 
of the qPCR results were expressed relative to HPRT, 
which is an endogenous housekeeping gene (Schmid   
et al., 2009). We measured elevated levels of Lyn tyro-
sine kinase in activated C8-B4 cells. Of the seven P2X sub-
units, we failed to detect transcripts for P2X1, P2X2, 
and P2X5 above levels observed in samples that were 
analyzed identically, but contained no template for 
PCR, suggesting that these transcripts are found at   
negligible  background  levels.  We  found  significant 
amounts of P2X3, P2X4, P2X6, and P2X7 transcripts in 
resting C8-B4 cells with the following relative expres-
sion levels: P2X7 > P2X4 > P2X3 > P2X6. However, of 
these,  only  P2X4  transcript  levels  were  significantly   
increased by 2.4-fold in C8-B4 cells activated (Fig. 3)   
using conditions that give rise to ATP-evoked inward 
currents (Fig. 2).
Analysis of P2X4 subunit protein expression in resting  
and activated C8-B4 cells
In principle, the increased P2X4 mRNAs (Fig. 3) could 
explain why ATP-evoked currents in C8-B4 cells were   
increased during the activated state. We explored this 
using Western blot analysis of total P2X4 proteins from 
resting  and  activated  C8-B4  cells.  We  resolved  equal 
amounts of total proteins (10 µg) by SDS-PAGE and 
analyzed the intensity of the protein bands normalized 
to that of  actin. The molecular weights of both P2X4 
and  actin were as expected from previous studies at 65 
and 42 kD (a “full” gel is shown in Fig. S1). We found 
that C8-B4 cell activation with LPS did not lead to an   
increase in total P2X4 protein levels (Fig. 4; n = 3). We 
emphasize  that  LPS  was  applied  using  a  protocol   
that always resulted in significant ATP-evoked inward 
desensitization ( = 267 ± 55 ms) during 2-s applications 
of 100 µM ATP (n = 7). The ATP-evoked currents also 
displayed minimal rundown for repeated ATP applica-
tions to the same cell (28 ± 4% after five 2-s 100-µM ATP 
applications  5  min  apart;  n  =  5).  The  ATP-evoked   
inward currents at 60 mV were associated with an   
increase in membrane conductance of 2.8 ± 0.3 nS   
(n = 5), implying the opening of membrane channels.
We also performed a set of experiments to determine 
if the effect of LPS was specific to ATP-evoked inward 
currents. Using Fluo-4 imaging of intracellular calcium 
levels ([Ca
2+]i), we found that 100 µM UTP application 
to activate P2Y receptors (Inoue, 2008) elevated [Ca
2+]i 
equally in resting and activated C8-B4 cells (Fig. 2 C). In 
contrast,  100  µM  ATP  elevated  [Ca
2+]i  most  robustly 
only in activated C8-B4 cells. This effect was abolished 
in nominally Ca
2+-free extracellular solutions (Fig. 2 C), 
demonstrating that ATP activates a calcium-permeable 
membrane  pathway.  FURA-based  calcium  imaging 
showed that the resting calcium concentration in C8-B4 
cells was 83 ± 11 nM, but it increased to 401 ± 101 nM in 
response to ATP in activated cells (n = 18). In contrast 
to  the  enhanced  ATP-evoked  currents  in  activated   
C8-B4 cells, we did not measure any GABA, ACh, and 
glutamate-evoked inward currents (n = 6–8; 100 µM), 
suggesting that C8-B4 cell activation did not affect all 
ionotropic receptors (Fig. 2 D).
qPCR analysis of P2X subunit transcript levels in resting 
and activated C8-B4 cells
We used qPCR to shed light on the P2X receptor tran-
scripts expressed in resting and activated C8-B4 cells. 
For these experiments, we also analyzed Lyn tyrosine   
kinase  as  a  positive  control  because  its  expression  is   
Figure 3.  Up-regulation of P2X4 transcripts in activated C8-B4 cells as revealed by qPCR. The bar graph summarizes qPCR experiments 
in control (LPS) and activated C8-B4 cells (+LPS), with the data normalized to HPRT expression levels (see Materials and methods). 
By this analysis, only Lyn tyrosine kinase and P2X4 mRNA levels were elevated in activated C8-B4 cells. The bars represent mean ± SEM 
from n observations as indicated on the graph. Comparisons were made between control and activated C8-B4 cells using the unpaired 
Student’s t test, and significance was declared if P < 0.05. Note the y axis is on a log scale so that all of the data bars are easily visible on the 
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In recombinant systems, rat P2X4 receptors display sig-
nificant time-dependent increases in organic cation per-
meability and dye uptake into cells (Khakh et al., 1999a; 
Virginio et al., 1999; Toulmé et al., 2006), whereas mouse 
P2X4 receptors do not (Casas-Pruneda et al., 2009). We 
next tested to see if the ATP-evoked inward currents in 
mouse-activated C8-B4 cells also displayed these prop-
erties.  With  NMDG
+  as  the  main  extracellular  cation,   
the ATP-evoked inward current had a reversal potential 
of 40 ± 3 mV (n = 7), whereas the reversal potential for 
the cells with Na
+ as the extracellular cation was +5 mV   
(Fig.  6  D).  This  suggests  a  pNMDG
+/pNa
+  of  0.17 
(Eickhorst et al., 2002). Furthermore, we did not mea-
sure  any  time-dependent  changes  in  NMDG
+  reversal   
potentials in the presence of 100 µM ATP, and we failed 
to measure ATP-evoked YOPRO1 dye uptake in activated 
C8-B4  cells,  whereas  cell  permeabilization  with  Triton 
currents  (Figs.  1  and  2),  which  we  verified  for  the 
batches  of  cells  used  for  Western  blot  analysis.  This   
result is consistent with work on P2X4 knock-out mice 
showing  that  genomic  regulation  of  P2X4  may  be  a 
marker of microglial activation and can occur in the 
complete  absence  of  P2X4  proteins  (Ulmann  et  al., 
2008).  In  a  later  section,  we  examine  surface  P2X4   
expression  in  resting  and  activated  microglia  using   
surface biotinylation.
Analysis of P2X3, P2X6, and P2X7 protein expression  
in resting and activated C8-B4 cells
Based on the qPCR results (Fig. 3), we used Western 
blot  analysis  to  determine  if  P2X3,  P2X6,  and  P2X7   
proteins were expressed in C8-B4 cells. We also used   
HEK-293 cells as negative controls and HEK-293 cells 
transfected  with  P2X3,  P2X6,  and  P2X7  plasmids  as 
positive controls for each antibody (correctly migrating 
proteins  were  detected  in  transfected  HEK-293  cells; 
Fig. 5, A–C; n = 3). With these controls in hand, we   
examined C8-B4 cells and found no evidence for the 
expression of P2X3 or P2X6 proteins in resting or   
activated C8-B4 cells (Fig. 5, A–C; n = 3). However, we 
found a clear but faint band indicative of P2X7 expres-
sion in resting C8-B4 cells. The intensity of this band 
(relative to  actin) did not differ significantly between 
resting and activated cells, although there was a small 
trend for it to increase (Fig. 5 C; P > 0.05). We next used 
surface  biotinylation  to  determine  if  P2X7  proteins 
were expressed on the surface of C8-B4 cells and found 
no evidence of this in resting or activated cells from 
three separate experiments (one representative gel is 
shown on the right of Fig. 5 C).
Properties of ATP-evoked currents in activated C8-B4 cells
We  applied  voltage  ramps  from  120  to  +60  mV   
(in 200 ms) every 1 s before, during, and after the appli-
cation  of  100 µM ATP to resting and activated C8-B4   
cells (Fig. 6 A). From these experiments, we found that 
the ATP-evoked inward current had a reversal potential 
of +5 ± 1 mV (with 130 mM Na
+ outside and 130 mM K
+  
inside; n = 5) and displayed weak inward rectification   
(Fig. 6 B). ATP failed to evoke any currents in resting 
C8-B4 cells over membrane voltages between 120   
and +60 mV (n = 5; Fig. 6 B). We also measured the Pf% of 
ATP-evoked currents from resting and activated C8-B4 
cells (Egan and Khakh, 2004; Egan et al., 2006). For rest-
ing C8-B4 cells, we measured negligible inward currents 
and negligible changes in FURA fluorescence and thus 
could not calculate a Pf% value (n = 5; Fig. 6 C). In con-
trast, in activated C8-B4 cells we measured robust ATP-
evoked inward currents and significant changes in FURA 
fluorescence, which displayed a time course identical to 
the integral of the current (Fig. 6 C, QT). From these re-
cords, we calculated the Pf% value of the ATP-evoked in-
ward current in activated C8-B4 cells to be 17 ± 1% (n = 7).
Figure 4.  Total P2X4 protein levels are the same for resting and 
activated C8-B4 cells. The gel image shows bands for P2X4 and  
actin probed with epitope-specific antibodies. The bottom graph 
shows average band intensities for three such experiments. The 
intensity of the bands was normalized with respect to the intensity 
of  actin in the absence of LPS. For these experiments, 10 µg   
of protein was loaded per well. The bar graph is an average   
from three experiments, with the P2X4 band intensities (LPS 
and +LPS) normalized with respect to  actin. For this dataset, the 
mean values were 0.57 ± 0.04 and 0.61 ± 0.1 for LPS and +LPS, 
respectively. The raw values for the three experiments were 0.60, 
0.62, and 0.50, and 0.82, 0.53, and 0.49, respectively, for the LPS   
and +LPS condition. Thus, statistical analysis clearly shows that the 
total P2X4 protein band intensities are not different between LPS 
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role of P2X4 further using IVM, which is a positive allo-
steric modulator of P2X4 receptors (Khakh et al., 1999b; 
Priel and Silberberg, 2004), and found that this mole-
cule increased peak ATP-evoked currents (2.4-fold for 
10 µM ATP with 3 µM IVM; n = 5), increased their dura-
tion (10-fold), and increased the potency of ATP 3.4-
fold (Fig. 7 C; n = 5). The ATP-evoked currents were 
also augmented by 10 µM Zn
2+ and 30 µM suramin and 
blocked  significantly  by  1  µM  2,3-O-(2,4,6-trinitro-
phenyl) ATP (TNP-ATP) and 10 µM pyridoxal-phosphate- 
6-azophenyl-2,4-disulfonic acid (PPADS), recalling the 
properties  of  recombinant  mouse  P2X4  receptors   
expressed in HEK cells (Jones et al., 2000). The block 
by  TNP-ATP  is  also  consistent  with  a  role  for  P2X4   
receptors (Fig. 7 D) (Surprenant and North, 2009).
Interestingly,  the  P2X7  antagonist  brilliant  blue  G 
(BBG) had no significant effect on the ATP-evoked cur-
rents. However, to fully address the possible involvement 
of P2X7 receptors, we performed an additional set of 
experiments. Thus, we compared peak ATP (100 µM) 
and BzATP (30 µM) responses from resting and acti-
vated C8-B4 cells in normal solutions containing 1 mM 
evoked large YOPRO1 uptake (Fig. 6 E). These observa-
tions are similar to those with mouse recombinant P2X4 
receptors (Casas-Pruneda et al., 2009).
Pharmacological properties of P2X receptors in activated 
C8-B4 cells
ATP and several ATP congeners activated inward currents 
in a concentration-dependent manner (Fig. 7, A and B). 
The  most  potent  agonist  was  ATP,  with  an  EC50  of   
33 µM. ,-Methylene ATP was a partial agonist, and 
benzoyl-benzoyl ATP (BzATP) was quite ineffective, dis-
playing a high EC50 at 106 µM and low maximal response 
relative to ATP (20% of peak; Fig. 7 B). The low po-
tency of BzATP relative to ATP strongly argues against 
homomeric  P2X7  receptors  (Surprenant  and  North, 
2009). That said, the ATP EC50 for native C8-B4 cells 
P2X4 receptors at 33 µM was somewhat higher than for 
rodent P2X4 receptors expressed in HEK cells that have 
been reported to be between 2 and 12 µM (Jones et al., 
2000; Silberberg et al., 2005). This is reminiscent of dif-
ferences between natively and heterologously expressed 
P2X2 receptors (Khakh et al., 2001). We explored the 
Figure  5.  P2X3,  P2X6,  and  P2X7 
protein expression analysis in resting 
and activated C8-B4 cells. (A) The   
gel  images  show  Western  blot  re-
sults for P2X3 and  actin proteins 
probed  with  specific  antibodies   
under the conditions indicated by 
the  key  above  (i–iv).  The  bottom 
graph shows average band intensi-
ties  for  three  such  experiments. 
The intensity of the bands was nor-
malized with respect to the intensity 
of  actin. In this case, we detected 
a  P2X3  band  only  in  HEK-293   
cells transfected with P2X3 cDNAs. 
(B and C) Images and data as in A, 
but  for  P2X6  and  P2X7  proteins. 
The  right-hand  gels  in  C  are  rep-
resentative  of  three  experiments 
where we examined the expression 
of P2X7 receptors on the cell sur-
face using biotinylation. We found 
no evidence of P2X7 expression on 
the cell surface; the lack of signal to 
 actin confirms that the fractions 
were  a  membrane  pool.  Similar 
experiments  with  P2X4  revealed 
strong expression on the cell surface   
(Fig.  9).  In  some  cases,  the  error 
bars are smaller than the bars rep-
resenting the mean.  Toulme et al. 341
total P2X4 proteins (Fig. 4), suggesting that enhanced 
trafficking to the plasma membrane may be responsible 
for  the  ATP-evoked  currents  in  activated  C8-B4  cells 
(Bobanovic et al., 2002; Qureshi et al., 2007). Using an 
antibody raised against the P2X4 receptor cytosolic   
domain and immunocytochemistry, we found that P2X4 
expression was spotty, with fluorescence observed with-
  in  many  vesicle-like  structures  in  permeabilized  cells 
(Fig. 9 A). The larger vesicles were reminiscent of lyso-
somes (Qureshi et al., 2007) and in accord localized 
with the lysosomal marker LAMP1 (Fig. 9 A). We ana-
lyzed  the  colocalization  between  P2X4  and  LAMP1   
using dual-color confocal microscopy and assessed the 
degree of colocalization using the Pearson’s correlation 
coefficient (r; see Data analysis in Materials and methods). 
Mg
2+ to those with 0.1 mM Mg
2+, which is expected to 
increase  BzATP-evoked  P2X7  receptor–mediated  re-
sponses. Contrary to this, we found that 0.1 mM Mg
2+ 
had no effect on BzATP-evoked currents, which re-
mained small in relation to the much larger ATP-evoked 
responses (Fig. 8, A–C). Additionally, we note that the 
ATP EC50 at 33 µM for the activated C8-B4 cells (Fig. 6 A) 
was markedly lower than that previously reported for 
P2X7 receptors at >200–500 µM (Khakh et al., 2001).
Mechanism of P2X receptor up-regulation in activated  
C8-B4 cells
We could measure significantly enhanced P2X4-medi-
ated currents using electrophysiology during the acti-
vated state (Fig. 2), but failed to detect elevated levels of 
Figure  6.  Properties of ATP-evoked cur-
rents  in  activated  C8-B4  cells.  (A;  left) 
Concatenated traces of membrane voltage 
ramps  applied  before,  during,  and  after 
the application of 100 µM ATP to a single 
activated  C8-B4  cell.  The  traces  labeled 
as  a,  b,  and  c  are  shown  expanded  on 
the current–voltage relation on the right. 
The current–voltage relation of the ATP-
evoked current is shown in blue for this 
representative cell. For this, we used b–c 
to calculate IATP. (B) The average data for 
five resting and five activated C8-B4 cells. 
For activated C8-B4 cells, the ATP-evoked 
current was slightly inwardly rectifying and 
reversed direction at +5 mV. ATP failed to 
evoke any inward currents in resting C8-B4 
cells. (C) The black traces are ATP-evoked 
currents  (ampere  units),  the  red  traces 
are the integral of the current (QT in nC 
units), and the blue traces are the F380 
of FURA (in BUs). ATP evoked negligible 
inward currents and changes in FURA fluo-
rescence  in  resting  C8-B4  cells  (LPS), 
but it evoked significant inward currents 
and changes in FURA fluorescence in ac-
tivated  C8-B4  cells.  Traces  such  as  these 
were used to calculate the Pf% of the ATP- 
evoked currents in activated C8-B4 cells,   
as  described  in  Materials  and  methods. 
(D) Current–voltage relations for 100-µM 
ATP-evoked  currents  in  activated  C8-B4 
cells in the presence of NMDG
+ as major 
extracellular cation. (E) Plots YOPRO1 
fluorescence  intensity  over  time  for  five 
and six resting and activated C8-B4 cells. 
100 µM ATP failed to evoke YOPRO1 up-
take  in  resting  or  activated  C8-B4  cells, 
whereas  cell  permeabilization  with  0.1% 
Triton did so. All of the ATP-evoked cur-
rents were measured at a holding voltage 
of 60 mV.342 P2X receptors in C8-B4 cells
Cognizant of the aforementioned limitations of using 
immunocytochemistry, we used surface biotinylation of 
membrane proteins to obtain more direct data to sup-
port our hypothesis that C8-B4 cell activation results in 
elevated P2X4 expression in the plasma membrane. For 
these experiments, we used  actin as a control to en-
sure that the membrane fractions were indeed plasma 
membrane, as these should lack  actin signal (Bannai 
et al., 2009). In accord, we found no  actin signal in 
plasma membrane fractions from resting or activated 
C8-B4 cells. Moreover, we found only a faint band cor-
responding to P2X4 in the resting C8-B4 cells. Impor-
tantly, this band was significantly increased in intensity 
for activated C8-B4 cells (n = 3; Fig. 9 D and Table I).
We hypothesized that increased ATP-evoked currents 
in activated C8-B4 cells are because of lysosomal secre-
tion. Before proceeding further, we tested the effect of 
the Src family tyrosine kinase inhibitor PP2 (20 µM for 
4 h with LPS) because previous work shows that this re-
duces P2X4 expression in microglia (Tsuda et al., 2008). 
Consistent with this, we found that PP2 significantly re-
duced  ATP-evoked  currents  recorded  from  activated 
C8-B4 cells, whereas the inactive homologue PP3 did 
In resting C8-B4 cells, Pearson’s coefficient was 0.75, 
implying significant colocalization between P2X4 and 
LAMP1 (n = 6; Fig. 9 C). We repeated the immunocyto-
chemistry experiments in activated C8-B4 cells and 
found that the P2X4 expression profile was now mark-
edly  less  spotty,  with  far  fewer  large  vesicles  being   
apparent (Fig. 9 B). Also, the P2X4 receptor colocal-
ization with LAMP1 was significantly reduced, as as-
sessed across different experiments using Pearson’s 
coefficient, which was reduced to 0.5 (n = 9; Fig. 9 C). 
We also tried to use immunocytochemistry to image 
enhanced levels of P2X4 near the plasma membrane 
of activated C8-B4 cells. Despite many attempts, the 
P2X4 immunocytochemistry images were never reli-
able enough, likely because confocal microscopy can-
not sample the plasma membrane independently of 
submembrane and cytosolic fluorescence (Jaiswal and 
Simon, 2007). This limitation is increased by the fact 
that available P2X4 antibodies target a cytosolic do-
main epitope and require cell permeabilization, ren-
dering the increase in plasma membrane expression   
of  P2X4  difficult  to  detect  against  a  much  larger   
cytosolic component.
Figure 7.  Pharmacological properties 
of ATP-evoked currents in activated C8-
B4 cells. (A) Representative traces for 
concentration-dependent  ATP-evoked   
inward currents recorded from activated 
C8-B4 cells. (B) Concentration–effect 
curves for ATP and three analogues.   
(C) Representative traces for the ability 
of 3 µM IVM to increase the peak and   
duration of 10-µM ATP-evoked responses 
recorded  from  activated  C8-B4  cells. 
The graph to the right shows the effect   
of  IVM  on  the  ATP  concentration–
  response curve. (D) Summary bar graph 
showing the effect of several known 
P2X  modulators  and  antagonists  on 
peak  ATP-evoked  responses  recorded 
from  individual  activated  C8-B4  cells 
(10  µM  ATP  was  used  in  each  case). 
The concentrations of the agents were: 
3 µM IVM, 10 µM Zn
2+, 30 µM suramin, 
1 µM TNP-ATP, 10 µM PPADS, and 1 µM 
BBG. Each bar represents mean data 
between five and six cells. All of the 
ATP-evoked currents were measured at 
a holding voltage of 60 mV.  Toulme et al. 343
implies that P2X4 currents are small in resting C8-B4 
cells because the channels are targeted to lysosomes, 
and that secretion of this lysosomal pool (by MA or in 
the  activated  state)  equally  elevates  P2X4  responses.   
We next sought to determine whether this lysosomal 
pool of P2X4 receptors draws on dynamin-dependent   
receptor endocytosis from the plasma membrane. Thus, 
we used the dynamin-dependent endocytosis inhibitor 
not (20 µM for 4 h with LPS; Fig. 10). With this positive 
control in hand, we used the weak base methylamine 
(MA; 50 mM for 30 min) to trigger lysosomal secretion 
to the plasma membrane and asked if ATP-evoked cur-
rents were larger. Thus, in resting C8-B4 cells, we found 
that ATP-evoked currents were considerably larger in 
cells treated with MA than those measured in resting 
C8-B4  cells  without  MA  treatment  (Fig.  10).  This   
Figure 8.  Comparison of ATP- and BzATP-evoked currents in resting and activated C8-B4 cells in extracellular buffers containing 1 and 
0.1 mM Mg
2+. (A) Representative traces for BzATP- and ATP-evoked currents recorded from resting and activated C8-B4 cells in normal 
extracellular buffer containing 1 mM Mg
2+. Note that neither ATP nor BzATP evoked inward currents in resting C8-B4 cells, and that 
the BzATP-evoked current in activated C8-B4 cells was far smaller than that evoked by ATP. (B) As in A, but for extracellular buffers 
containing 0.1 mM Mg
2+. The use of 0.1 mM Mg
2+ should reveal the presence of P2X7 receptor responses (if they were present) as larger 
BzATP-evoked currents (see Results). (C) Summary data for experiments such at those shown in A and B for between 5 and 11 cells. All 
of the ATP-evoked currents were measured at a holding voltage of 60 mV.
TA B L E   I
Summary for P2X responses in C8-B4 cells
Experimental observation C8-B4 cell condition Analysis of changes
Resting  
(LPS)
Activated  
(+ LPS)
Activated plus 
amitriptyline
Fold change  
(resting vs. activated)
Fold change  
(activated vs. activated plus 
amitriptyline)
P2X4 mRNA levels
a,b 0.21 ± 0.02 0.35 ± 0.02 0.17 ± 0.005 1.6 0.6
Total P2X4 protein levels
c 0.5 ± 0.2 0.5 ± 0.1 0.5 ± 0.2 1 1
IATP (pA/pF)
d 0 3.6 ± 0.5 1.5 ± 0.2 ND 0.4
Surface P2X4 protein levels
e 1 3.5 ± 1 1.7 ± 0.2 3.5 0.5
P2X4/LAMP1 colocalization
f 0.7 ± 0.06 0.4 ± 0.02 0.8 ± 0.09 0.6 2.0
The n numbers for each experimental group are provided in the text and figures. ND, not determinable (point 3 above).
aExpressed relative to HPRT mRNA levels as measured by qPCR (the mean ± SEM data are presented in Fig. 3).
bThese data are for this direct comparison (n = 8). Another eight experiments where P2X4 was compared to other P2X subunit transcripts are shown in 
Fig. 3.
cExpressed relative to  actin band intensities from Western blot analysis (Fig. 4).
dCurrents evoked by 100 µM ATP measured at 60 mV (Fig. 2). In the LPS condition, most cells did not respond to ATP, and the remainder showed 
negligible ATP-evoked currents. When averaged across all LPS C8-B4 cells, the ATP-evoked current was essentially 0, precluding the calculation of a 
fold-change in IATP.
eAs measured by surface biotinylation and expressed as normalized to the LPS condition (Fig. 9).
fColocalization was assessed using the Pearson’s correlation coefficient (see Data analysis in Materials and methods and Fig. 9). Values between 0.5 and 1.0 
are considered to represent meaningful colocalization.344 P2X receptors in C8-B4 cells
high tens of micromolar concentrations (Nagata et al., 
2009), but in a later section, we also present data with 
low micromolar concentrations. We found that none 
of the antidepressants examined produced significant 
block  of  the  ATP-evoked  responses  recorded  from   
activated C8-B4 cells (Fig. 11 A). Next, we pre-applied 
each antidepressant for 59 s, removed it from the 
bath for 50 ms, and applied 100 µM ATP for 1 s to 
determine if these responses were altered (Fig. 11 B). 
Again,  we  found  no  significant  effects  for  10  µM 
fluoxetine, 50 µM amitriptyline, or 50 µM desipra-
mine on P2X4 receptors in C8-B4 cells. However, we 
did  observe  a  significant  25%  reduction  in  ATP-
evoked responses by pre-applying 10 µM paroxetine 
(Fig. 11 B). Overall, these experiments do not pro-
vide strong evidence to suggest that antidepressants 
are antagonists of P2X4 receptors in C8-B4 cells, even 
at high concentrations.
dynasore (Macia et al., 2006) (80 µM for 45 min) and 
found  that  this  increased  ATP-evoked  currents  in   
resting cells to levels equal to those of activated C8-B4 
cells (Fig. 10). In the simplest case, these data suggest 
that the level of P2X4 proteins on the plasma mem-
brane is kept low in resting C8-B4 cells because of   
endocytosis and shuttling to lysosomes.
Antidepressants do not markedly inhibit, block,  
or otherwise antagonize C8-B4 cell P2X4 receptors
A  recent  study  suggested  that  antidepressant  drugs 
used to treat neuropathic pain act as P2X4 inhibitors 
(Nagata et al., 2009). We determined if several com-
monly used antidepressants (paroxetine, fluoxetine, 
desipramine,  and  amitriptyline;  see  Figs.  11–14  for 
experimental  details)  blocked  P2X4  receptor  re-
sponses in activated C8-B4 cells. For the initial experi-
ments, we used the antidepressant drugs at relatively 
Figure 9.  Reduced lysosomal colocalization and increased surface trafficking of P2X4 receptors in activated C8-B4 cells. (A) Represen-
tative confocal images show staining for P2X4 (left) and LAMP1 (middle), and costaining for these two epitopes in the merged image 
(right). In the right panel, the white arrows point to regions of strong colocalization between P2X4 and LAMP1. (B) Experiments similar 
to those shown in A, but for activated C8-B4 cells (+LPS). (C) Mean and individual values for the Pearson’s coefficient (r), which rep-
resents 0 and maximal colocalization between P2X4 and LAMP1 on a scale between 0 and 1 (see Results and Data analysis in Materials 
and methods). Note that there was a significant decrease in r for activated C8-B4 cells (+LPS). (D) The Western blot shows protein bands 
for P2X4 and  actin from membrane proteins isolated by surface biotinylation. No  actin staining was detected, confirming that the 
loaded proteins lacked cytosolic contamination. In the absence of LPS, a very weak band corresponding to P2X4 was seen. However, the 
intensity of this band was largely increased in activated C8-B4 cells. For any one gel, the bands were from samples loaded and resolved 
in the same gel, and the image of all bands was captured simultaneously. The bar graph to the right shows the average data for three 
experiments, such as those shown by the exemplar gel. There was a significant increase in surface P2X4 expression in activated C8-B4 
cells as compared with resting C8-B4 cells. Bar, 10 µm.  Toulme et al. 345
Pearson’s coefficient equal to that of resting C8-B4 cells 
(Fig. 13, A–D), implying that this antidepressant may 
act on lysosomes to hinder secretion of P2X4 onto the 
plasma membrane. During the course of these experi-
ments, we also observed that LAMP1-labeled lysosomes 
in control cells displayed an average area of 1 µm
2, 
whereas those in cells treated with amitriptyline had a 
larger size at 4 µm
2 (Fig. 13 E).
The data described in the previous paragraph sug-
gest that antidepressants may alter lysosome function 
and  perhaps  render  them  incompetent  for  mem-
brane secretion. This provided a unique opportunity 
by allowing us to use 1 µM amitriptyline as a method 
to impair lysosomal function and ask if surface levels 
and functional P2X4 receptor responses in activated 
C8-B4  cells  were  altered  in  a  predictable  manner. 
Specifically,  if  lysosomal  function  is  impaired  with 
amitriptyline, this makes several testable predictions 
for  P2X4  receptor  surface  expression  and  electro-
physiological  responses  in  activated  C8-B4  cells.  It 
predicts that (a) amitriptyline should not affect total 
P2X4 proteins levels in activated C8-B4 cells (Fig. 14 A), 
(b)  amitriptyline  should  reduce  surface  expression 
of P2X4 in activated C8-B4 cells (Fig. 14 B), (c) the 
effect of LPS to cause C8-B4 cells activation, and of 
MA to cause lysosomal secretion, would not be addi-
tive, as both strategies draw on the same lysosomal 
pool of P2X4 receptors (Fig. 14 C), and (d) the abil-
ity  of  MA  to  increase  P2X4  responses  would  be   
reduced by amitriptyline if this drug affects lysosomes 
directly (Fig. 14 C). All of these predictions were sup-
ported by empirical data (Fig. 14), suggesting that 
antidepressants lead to reduced P2X4 responses be-
cause they impair lysosomal function.
Pre-application of antidepressants reduces P2X4 
responses by reducing surface expression due to  
an effect on lysosomes
We next determined whether amitriptyline, desipra-
mine, fluoxetine, and paroxetine could affect P2X4   
receptor  up-regulation  in  activated  C8-B4  cells.  We 
started by pre-incubating C8-B4 cells with antidepres-
sants and LPS together (Fig. 12). When pre-applied   
in this manner, we found that all of the antidepres-
sants  tested  resulted  in  significantly  reduced  ATP-
evoked P2X4 currents in activated C8-B4 cells (Fig. 12, 
A and B; n = 4–9 for each). This result is in contrast   
to their minimal effects when applied for brief periods 
of time before and during ATP applications (Fig. 11). 
We  next  performed  a  specific  set  of  experiments   
with a range of concentrations and found significant 
(45–50%)  reductions  in  ATP-evoked  currents  at   
500-nM concentrations of each antidepressant (Fig. 12 B). 
This concentration is in the range of serum levels of 
antidepressants in humans at 100–1,000 nM (Baldes-
sarini, 2006).
Why do pre-applications of antidepressants lead to a re-
duction in P2X4 receptor responses in activated C8-B4 
cells (Fig. 12), even though these drugs do not inhibit 
P2X4 receptors directly (Fig. 11)? We explored the 
possibility that antidepressants reduce ATP-evoked cur-
rents in activated C8-B4 cells by impairing up-regulation   
of P2X receptors; a process our data suggest is due to   
lysosomal secretion of P2X4 (Figs. 1–10). The data 
shown  in  Fig.  9  demonstrate  reduced  colocalization   
between P2X4 and LAMP1 in activated C8-B4 cells as 
compared with non-activated cells. In the presence of   
1 µM amitriptyline (n = 7), activated C8-B4 cells showed 
strong colocalization between LAMP1 and P2X4, with a 
Figure  10.  Blocking  dynamin-dependent  endo-
cytosis or triggering lysosomal secretion in resting 
C8-B4 cells results in ATP-evoked currents equiva-
lent to those measured in activated cells. Represen-
tative  traces  (top)  and  summary  data  for  100-µM 
ATP-evoked responses recorded from control and 
activated  C8-B4  cells  (+LPS)  in  the  absence  and 
presence of the Lyn tyrosine kinase inhibitor PP2 
(20 µM) and the inactive homologue of PP2 called 
PP3 (20 µM; these were coincubated for 4 h with 
LPS). Data are also shown for ATP-evoked responses 
recorded from control C8-B4 cells (in the absence   
of LPS treatment) after the cells had been treated 
with dynasore (80 µM for 45 min) or MA (50 mM 
for 30 min). The bar graphs represent data from   
n = 9–14 experiments. All of the ATP-evoked currents 
were measured at a holding voltage of 60 mV.346 P2X receptors in C8-B4 cells
processes in cells treated with 1 µM amitriptyline alone 
(3 ± 0.3 processes/cell; n = 7) as well as with 1 µg/ml 
LPS plus 1 µM amitriptyline (2 ± 0.03 processes per cell; 
n = 11). These data, along with those in Fig. 1 B, suggest 
that amitriptyline does not affect the number of pro-
cesses per cell (3) and also does not reduce the ability 
of LPS to cause fewer processes per cell (2 at 6 h). 
From this perspective, amitriptyline does not lead to the 
recovery  of  C8-B4  cell  processes,  implying  that  the   
effect of amitriptyline on lysosomes is separate from this 
facet of C8-B4 cell biology.
D I S C U S S I O N
The main findings of this study are illustrated in Fig. 15, 
and several informative pieces of data are summarized 
in Table I. First, we report the properties of P2X recep-
tors in resting and activated C8-B4 cells. Second, we 
show  that  C8-B4  cells  express  significant  amounts  of 
functional  P2X  receptors  only  in  the  activated  state. 
Third,  we  report  that  up-regulated  P2X  receptors  in   
activated  C8-B4  cells  are  most  similar  to  homomeric 
P2X4 receptors. Fourth, the up-regulated P2X4 recep-
tors in activated C8-B4 cells are from a preexisting lyso-
somal pool that is trafficked to the plasma membrane. 
Fifth, C8-B4 cell activation results in up-regulation of 
P2X4 transcripts, but this is not associated with any mea-
surable  increase  in  total  P2X4  protein  levels.  Sixth,   
several antidepressants appear to be weak or ineffective 
antagonists of P2X4 receptors in C8-B4 cells. Seventh, sev-
eral antidepressants at 500-nM concentrations impair 
lysosome function, which secondarily blocks cell surface 
up-regulation  of  P2X4  receptors  in  activated  C8-B4 
cells. Eighth, we provide the first measure for the Pf% 
for a natively expressed P2X4 receptor.
Similarities and differences to past work with P2X4 
receptors in immune cells
Significant progress has been made in understanding 
the role of microglial P2X4 receptors in neuropathic 
pain (Tsuda et al., 2005; Trang et al., 2006; Inoue, 2008; 
Ulmann et al., 2008). However, despite this progress, 
there have only been a limited number of reports on 
the electrophysiological properties of P2X receptors in 
control or activated microglia from other parts of the 
brain. For example, the study by Boumechache et al. 
(2009) only used biochemistry and did not examine the 
functional  properties  of  P2X  receptors  in  microglia. 
Moreover, in the study by Raouf et al. (2007), the mi-
croglia used expressed both P2X4 and P2X7 receptors. In 
that  study,  microglial  activation  for  48  h  led  to  an   
increase in P2X currents because more P2X4 proteins 
were made. As far as we know, our study is the first to   
report on P2X receptor properties and mechanisms in 
resting  and  activated  C8-B4  cells  that  are  of  cere-
bellar origin. Previous studies used cortical cultures   
Recall that C8-B4 cell activation with LPS (6 h) is   
associated with a reduction in the number of processes/
cell because the proportion of cells with three processes 
decreases (Fig. 1 B). We next counted the number of 
Figure 11.  Acute applications of antidepressants had little effect 
on ATP-evoked responses recorded from activated C8-B4 cells. 
(A) Representative traces and summary data for the effect of “test 
drugs” (antidepressants or IVM) on responses to ATP recorded 
from C8-B4 cells. The test drugs were applied at the indicated 
concentrations for the duration shown by the gray bar after the 
peak of the ATP response. None of the antidepressants produced 
significant block of ATP-evoked responses, whereas IVM potenti-
ated the currents when applied with the same protocol (see Data 
analysis in Materials and methods for how the percent block and 
potentiation were calculated). (B) Experiments from activated 
C8-B4 cells when test drugs (antidepressants or IVM at the con-
centrations shown) were applied in between 100-µM ATP applica-
tions after gathering two control responses. Using this protocol, 
we found that IVM caused a large potentiation of the ATP-evoked 
currents, but the antidepressants failed to cause substantial block 
of the responses. However, paroxetine did cause an 25% re-
duction in the ATP-evoked current (see Results). All of the ATP-
evoked currents were measured at a holding voltage of 60 mV.  Toulme et al. 347
macrophages express P2X4 receptors in their resting 
state and decrease expression of this protein when they 
enter the activated state (Stokes and Surprenant, 2009). 
This is the opposite of our data with C8-B4 cells, reveal-
ing the diversity of mechanisms that may regulate P2X4 
receptors in a cell- and context-specific manner.
Functional properties of P2X receptors in C8-B4 cells
Our experiments also allowed us to address whether   
C8-B4 cells express only P2X4 receptors in the activated 
state, or if they express multiple types of functional P2X 
receptors in resting and/or activated states. We found 
that resting C8-B4 cells expressed virtually no functional 
P2X receptors, and that activated C8-B4 cells expressed 
functional  P2X  receptors  that  are  most  like  homo-
meric P2X4 receptors. The findings that ATP-evoked   
currents in activated C8-B4 cells increased membrane 
conductance, displayed fast rise times, weak inward rec-
tification, and reversal potentials near 0 mV, and were 
activated between 3 and 100 µM ATP are all consistent 
with a role for P2X receptors in general (Surprenant 
and North, 2009). Based on the known single-channel 
properties of P2X4 receptors (Priel and Silberberg, 2004), 
(Boumechache et al., 2009), and the origin of the cells 
used  by  Raouf  et  al.  (2007)  is  unclear,  as  they  were   
derived from mixed brain cultures (Blasi et al., 1990). 
Our experiments suggest that the increase in peak ATP-
evoked currents recorded in C8-B4 cells may be ex-
plained by an 3.5-fold increase in trafficking of P2X4 
receptors to the cell surface from a lysosomal pool 
within 3 h of activation (Table I). We found no evi-
dence to suggest that the significant increase in P2X4 
mRNA also measured in activated C8-B4 cells led to ele-
vated levels of P2X4 proteins (Table I). However, our 
data  do  not  rule  out  the  possibility  of  elevated  total 
P2X4 protein levels over longer periods of microglial 
activation (Raouf et al., 2007). We could not address 
this directly, as we found that many of the C8-B4 cells 
were not viable at time points greater than 12 h after 
activation. In several ways, the functional properties of 
P2X receptors in activated C8-B4 cells recall those previ-
ously reported in alveolar macrophages (Bowler et al., 
2003; Stokes and Surprenant, 2009). However, the cell 
biology of C8-B4 cell P2X receptors presented in this 
study is quite different from that shown for P2X4 recep-
tors in macrophages. The available data suggest that 
Figure  12.  Pre-applications 
of  antidepressants  reduced 
ATP-evoked  responses  re-
corded  from  activated  C8-
B4  cells.  (A)  Representative 
traces and summary data for   
the effect of antidepressants   
(at the concentrations shown)   
on 100-µM ATP-evoked cur-
rents  recorded  from  acti-
vated  C8-B4  cells  (+LPS). 
All  of  the  antidepressants 
resulted  in  a  statistically 
significant reduction in the   
ATP-evoked  responses.  For 
these  experiments,  the  an-
tidepressants  were  applied 
with the LPS that is required 
to  trigger  C8-B4  cell  activa-
tion (see Results). The average 
data shown in the bar graph   
are  from  six  to  eight  cells.   
(B)  Summary  bar  graph  for 
experiments  as  shown  in  A, 
but  for  different  concentra-
tions  for  the  antidepressants, 
as shown in the figure. All of 
the drugs produced a signifi-
cant reduction in ATP-evoked 
currents at 500 nM. The bars 
represent mean data from five 
to nine cells. All of the ATP-
evoked  currents  were  mea-
sured at a holding voltage of 
60 mV.348 P2X receptors in C8-B4 cells
(Surprenant and North, 2009). The minimal effects 
and low potency of BzATP (in normal or reduced Mg
2+ 
solutions; Fig. 8) argues against P2X7 receptors (Khakh 
et al., 2001; Surprenant and North, 2009), whereas the 
augmentation of the ATP-evoked responses by suramin 
and  IVM  and  their  block  by  PPADS  and  TNP-ATP 
strongly suggest the involvement of a P2X4 subunit–
containing receptor (Khakh et al., 1999b; Jones et al., 
2000; Surprenant and North, 2009). Our data also allow 
us to consider if the P2X receptors in activated C8-B4 
cells are most like homomeric P2X4 receptors or het-
eromeric receptors containing this subunit. Pioneering 
our data suggest that resting C8-B4 cells have just a few 
(perhaps <10) P2X4 receptors per cell, and that this 
number increases to several hundred P2X4 receptors 
per cell during the activated state.
Our conclusion that the P2X receptors in activated 
C8-B4 cells are most like P2X4 receptors is based on the 
known properties of recombinant P2X receptors. The 
slow second time scale desensitization kinetics of the 
ATP-evoked responses strongly argues against P2X1 and 
P2X3 receptors that desensitize in milliseconds (Khakh 
et al., 2001; Surprenant and North, 2009). These data 
therefore favor P2X2, P2X5, P2X4, or P2X7 receptors 
Figure 13.  Antidepressants affect lysosomes. (A–C) Rep-
resentative images show staining for P2X4 (left) and 
LAMP1 (middle), and costaining for these two epitopes 
in the merged images (right). In the right panel, regions 
of strong colocalization between P2X4 and LAMP1 were 
observed (A and C), which were similar to the colocal-
ization observed between P2X4 and LAMP1 in control 
C8-B4 cells (Fig. 9 A). (D) The scatter graph summarizes 
analysis of the colocalization data gathered at the same 
time, which is shown as mean Pearson’s coefficients   
(n = 3–11). (E) Representative images of LAMP1-labeled 
lysosomes in control resting C8-B4 cells and for cells 
pretreated with 50 µM amitriptyline (repeat at lower 
dose). The bar graph to the right shows the average 
area of the LAMP1-labeled lysosomes; they were larger 
in cells treated with amitriptyline (n = 5). These experi-
ments are a summary of 11 cells from three samples that 
were treated with antidepressant. Bar, 10 µm.  Toulme et al. 349
P2X7  receptors  may  instead  undergo  functional   
interactions  (Casas-Pruneda  et  al.,  2009;  Murrell- 
Lagnado, 2009). Regardless, we found that BBG had 
no effect on the ATP-evoked currents recorded from 
activated C8-B4 cells, arguing against the expression 
of P2X4/P2X7 heteromeric or interacting receptors. 
Furthermore, the Pf% of the P2X receptors in C8-B4 
cells at 17% is most similar to recombinant P2X4 re-
ceptors at 12–16% (depending on the species) and 
significantly higher than the value for P2X7 recep-
tors at 6% (Egan and Khakh, 2004; Samways and 
Egan, 2007). Overall, the available data suggest that 
the functional receptors in activated C8-B4 cells are 
most likely homomeric P2X4 receptors.
work  suggested  that  recombinant  P2X4  receptors 
formed  heteromers  with  P2X5  and  P2X6  subunits   
(Lê et al., 1998a; Torres et al., 1999). However, the 
existence of a large pool of P2X4/5 heteromers in 
the present study is unlikely, as we failed to identify 
mRNA for P2X5 in C8-B4 cells. Similarly, we found 
no evidence of P2X6 proteins in C8-B4 cells, which 
together with the low potency of ,-methylene ATP 
strongly argues against P2X4/6 receptors in activated 
C8-B4 cells (Lê et al., 1998a). A recent expression 
study concluded that P2X4 and P2X7 subunits may 
also form heteromeric receptors that are blocked by 
micromolar concentrations of BBG (Guo et al., 2007), 
whereas subsequent studies indicated that P2X4 and 
Figure  14.  The  antidepressant  amitrip-
tyline reduces cell surface P2X4 receptor 
expression and peak ATP-evoked currents 
in activated C8-B4 cells. (A; top) A repre-
sentative gel for total proteins from cell ly-
sates of activated C8-B4 cells. The bottom 
graph  shows  quantitative  analysis  of  gels 
such as those shown in the top panel from 
three experiments. Neither 1 µg/ml LPS 
nor 1 µM amitriptyline had any effect on 
total P2X4 protein levels, when the data 
were analyzed with respect to the intensity 
of the  actin band. (B; top) A representa-
tive gel for cell surface proteins. Note that 
there was no band for  actin, confirming 
that  there  was  no  cytosolic  contamina-
tion of the samples. In these experiments, 
LPS caused an elevation in the amount of 
P2X4 proteins on the cell surface (see also 
Fig. 9). This effect was reduced by 1 µM 
amitriptyline (n = 4). (C) Representative 
traces  and  summary  data  for  peak  ATP-
evoked currents recorded from C8-B4 cells 
in the various conditions indicated. The 
effects of LPS and amitriptyline were non-
additive, and the ability of 1 µg/ml LPS 
and 50 mM MA to increase ATP-evoked 
responses  was  significantly  reduced  by   
50 µM amitriptyline (see Results and Fig. 11 
for data with lower concentrations). All of 
the ATP-evoked currents were measured at 
a holding voltage of 60 mV.350 P2X receptors in C8-B4 cells
The effect of antidepressants on P2X responses  
in C8-B4 cells
Neuropathic  pain  is  often  treated  with  antidepres-
sants, although their mechanisms of action remain 
somewhat obscure (Sindrup et al., 2005; Gilron et al., 
2006). A recent study showed that several antidepres-
sants used in neuropathic pain inhibit recombinant 
P2X4 receptors in astrocytoma cells (Nagata et al., 
2009), leading to the possibility that this may under-
lie their clinical effect and to the suggestion that they 
may  be  P2X4  receptor  antagonists.  Given  that  mi-
croglial up-regulation of P2X4 receptors has emerged 
as an important step in the initiation of neuropathic 
pain (Trang et al., 2006; Inoue, 2008), we experimentally 
determined whether antidepressants affected native   
C8-B4 cell P2X4 receptors directly or blocked their up- 
regulation. We found that four antidepressants that are 
commonly used to treat neuropathic pain did not mark-
edly block P2X4 receptors, even at high concentrations   
of tens of micromolars, greater than the levels likely to be 
clinically relevant. However, low concentrations of antide-
pressants, at 500 nM, that are likely to be clinically relevant 
(Baldessarini, 2006), reduced up-regulation of cell surface 
P2X4 receptors in activated C8-B4 cells, leading to smaller 
ATP-evoked responses, most likely because they interfered 
with lysosome function (Table I). These experiments im-
ply that the clinical efficacy of antidepressants in mouse 
models of neuropathic pain may not derive from their 
ability to block P2X4 receptors directly.
Potential future uses of C8-B4 cells in understanding P2X4 
receptor biology
First, the cells reported here can now be used to ex-
plore the functional properties of up-regulated P2X4 re-
ceptors. For example, these cells could be used to measure 
Trafficking of P2X4 receptors in C8-B4 cells
Detailed heterologous expression studies show that P2X4 
receptors undergo endocytosis and are targeted to 
lysosomes (Bobanovic et al., 2002; Royle and Murrell-
Lagnado, 2003; Royle et al., 2005; Toulmé et al., 2006; 
Qureshi et al., 2007). We used dynasore as a selective 
inhibitor of dynamin-dependent endocytosis (Macia 
et al., 2006) and found that it significantly increased 
ATP-evoked currents recorded from resting C8-B4 cells. 
Together with the vesicle-like staining that was observed 
for P2X4 in resting cells, these data suggest that the 
ATP-evoked  currents  in  resting  C8-B4  cells  are  small   
because  of  constitutive  P2X4  endocytosis  (Royle  and   
Murrell-Lagnado, 2003). We also observed P2X4 immuno-
staining in larger vesicle-like structures that were remi-
niscent of lysosomes (Qureshi et al., 2007; Stokes and 
Surprenant,  2009).  In  accord,  P2X4  colocalized  with 
the lysosomal marker LAMP1, confirming that native 
P2X4 receptors within resting C8-B4 cells are targeted 
to this intracellular organelle. Interestingly, costaining 
between P2X4 and LAMP1 was reduced in activated C8-
B4 cells and there were fewer large vesicles, implying 
that  P2X4  receptor  up-regulation  in  activated  C8-B4 
cells may result from lysosomal secretion of P2X4 re-
ceptors onto the plasma membrane (Table I). To ex-
plore this possibility, we used surface biotinylation and 
found increased levels of P2X4 protein in the mem-
branes of activated C8-B4 cells, which may explain the 
increase in peak currents observed during C8-B4 cell 
activation  (Table  I)  or  when  lysosomal  secretion  was 
triggered by MA (Qureshi et al., 2007). In fact, the ef-
fect of MA was equal to (and not additive with) that of 
LPS activation, strongly suggesting that the P2X recep-
tors that are up-regulated during the activated state of 
C8-B4 cells originate from lysosomes.
Figure 15.  A summary car-
toon  illustrating  the  mech-
anisms  regulating  P2X4 
receptor expression on the 
surfaces  of  resting  and  acti-
vated C8-B4 cells. In this view, 
P2X4 receptors are removed 
from the surface by dynamin- 
dependent  endocytosis  and 
trafficked to lysosomes. Con-
sequently, ATP is quite inef-
fective  in  evoking  inward 
currents  (Fig.  2),  and  there 
is little P2X4 protein on the 
membrane  (Fig.  9).  In  the 
activated  state,  lysosomal 
secretion  occurs,  resulting 
in  increased  surface  expres-
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